Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma

Julie H. Harreld, Emily M. Bratton, Sara M. Federico, Xingyu Li, William Grover, Yimei Li, Natalie C. Kerr, Matthew Wilson, Mary E. Hoehn

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Approximately 30% of patients with metastatic (stage M) neuroblastoma present with periorbital ecchymosis from orbital osseous disease. Though locoregional disease is staged by imaging, the prognostic significance of metastatic site in stage M disease is unknown. We hypothesize that, compared to nonorbital metastasis, orbital metastasis is associated with decreased survival in patients with stage M neuroblastoma, and that periorbital ecchymosis reflects location and extent of orbital disease. Procedure: Medical records and imaging from 222 patients with stage M neuroblastoma seen at St. Jude Children's Research Hospital between January 1995 and May 2009 were reviewed. Thirty-seven patients were <18 months of age at diagnosis and 185 were ≥18 months of age. Overall survival (OS) and 5-year survival (5YS) were compared for patients with and without orbital, calvarial and nonorbital osseous metastasis, and with and without periorbital ecchymosis (log-rank test). Associations of periorbital ecchymosis with orbital metastasis location/extent were explored (Fisher's exact test, t-test). Results: In patients ≥18 months of age, only orbital metastasis was associated with decreased 5YS (P = 0.0323) and OS (P = 0.0288). In patients <18 months of age, neither orbital, calvarial, or nonorbital bone metastasis was associated with OS or 5YS. Periorbital ecchymosis was associated with higher number of involved orbital bones (P = 0.0135), but not location or survival. Conclusions: In patients ≥ 18 months of age with stage M neuroblastoma, orbital metastatic disease is associated with decreased 5YS and OS. In future clinical trials, orbital disease may be useful as an imaging-based risk factor for substratification of stage M neuroblastoma.

Original languageEnglish (US)
Pages (from-to)627-633
Number of pages7
JournalPediatric Blood and Cancer
Volume63
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Neuroblastoma
Ecchymosis
Neoplasm Metastasis
Orbital Diseases
Survival
Bone and Bones
Diagnostic Imaging
Medical Records
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Harreld, J. H., Bratton, E. M., Federico, S. M., Li, X., Grover, W., Li, Y., ... Hoehn, M. E. (2016). Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma. Pediatric Blood and Cancer, 63(4), 627-633. https://doi.org/10.1002/pbc.25847

Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma. / Harreld, Julie H.; Bratton, Emily M.; Federico, Sara M.; Li, Xingyu; Grover, William; Li, Yimei; Kerr, Natalie C.; Wilson, Matthew; Hoehn, Mary E.

In: Pediatric Blood and Cancer, Vol. 63, No. 4, 01.04.2016, p. 627-633.

Research output: Contribution to journalArticle

Harreld, JH, Bratton, EM, Federico, SM, Li, X, Grover, W, Li, Y, Kerr, NC, Wilson, M & Hoehn, ME 2016, 'Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma', Pediatric Blood and Cancer, vol. 63, no. 4, pp. 627-633. https://doi.org/10.1002/pbc.25847
Harreld JH, Bratton EM, Federico SM, Li X, Grover W, Li Y et al. Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma. Pediatric Blood and Cancer. 2016 Apr 1;63(4):627-633. https://doi.org/10.1002/pbc.25847
Harreld, Julie H. ; Bratton, Emily M. ; Federico, Sara M. ; Li, Xingyu ; Grover, William ; Li, Yimei ; Kerr, Natalie C. ; Wilson, Matthew ; Hoehn, Mary E. / Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma. In: Pediatric Blood and Cancer. 2016 ; Vol. 63, No. 4. pp. 627-633.
@article{ed3c26f92c584e8a870c5ac93adc37e5,
title = "Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma",
abstract = "Background: Approximately 30{\%} of patients with metastatic (stage M) neuroblastoma present with periorbital ecchymosis from orbital osseous disease. Though locoregional disease is staged by imaging, the prognostic significance of metastatic site in stage M disease is unknown. We hypothesize that, compared to nonorbital metastasis, orbital metastasis is associated with decreased survival in patients with stage M neuroblastoma, and that periorbital ecchymosis reflects location and extent of orbital disease. Procedure: Medical records and imaging from 222 patients with stage M neuroblastoma seen at St. Jude Children's Research Hospital between January 1995 and May 2009 were reviewed. Thirty-seven patients were <18 months of age at diagnosis and 185 were ≥18 months of age. Overall survival (OS) and 5-year survival (5YS) were compared for patients with and without orbital, calvarial and nonorbital osseous metastasis, and with and without periorbital ecchymosis (log-rank test). Associations of periorbital ecchymosis with orbital metastasis location/extent were explored (Fisher's exact test, t-test). Results: In patients ≥18 months of age, only orbital metastasis was associated with decreased 5YS (P = 0.0323) and OS (P = 0.0288). In patients <18 months of age, neither orbital, calvarial, or nonorbital bone metastasis was associated with OS or 5YS. Periorbital ecchymosis was associated with higher number of involved orbital bones (P = 0.0135), but not location or survival. Conclusions: In patients ≥ 18 months of age with stage M neuroblastoma, orbital metastatic disease is associated with decreased 5YS and OS. In future clinical trials, orbital disease may be useful as an imaging-based risk factor for substratification of stage M neuroblastoma.",
author = "Harreld, {Julie H.} and Bratton, {Emily M.} and Federico, {Sara M.} and Xingyu Li and William Grover and Yimei Li and Kerr, {Natalie C.} and Matthew Wilson and Hoehn, {Mary E.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1002/pbc.25847",
language = "English (US)",
volume = "63",
pages = "627--633",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Orbital Metastasis Is Associated With Decreased Survival in Stage M Neuroblastoma

AU - Harreld, Julie H.

AU - Bratton, Emily M.

AU - Federico, Sara M.

AU - Li, Xingyu

AU - Grover, William

AU - Li, Yimei

AU - Kerr, Natalie C.

AU - Wilson, Matthew

AU - Hoehn, Mary E.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Background: Approximately 30% of patients with metastatic (stage M) neuroblastoma present with periorbital ecchymosis from orbital osseous disease. Though locoregional disease is staged by imaging, the prognostic significance of metastatic site in stage M disease is unknown. We hypothesize that, compared to nonorbital metastasis, orbital metastasis is associated with decreased survival in patients with stage M neuroblastoma, and that periorbital ecchymosis reflects location and extent of orbital disease. Procedure: Medical records and imaging from 222 patients with stage M neuroblastoma seen at St. Jude Children's Research Hospital between January 1995 and May 2009 were reviewed. Thirty-seven patients were <18 months of age at diagnosis and 185 were ≥18 months of age. Overall survival (OS) and 5-year survival (5YS) were compared for patients with and without orbital, calvarial and nonorbital osseous metastasis, and with and without periorbital ecchymosis (log-rank test). Associations of periorbital ecchymosis with orbital metastasis location/extent were explored (Fisher's exact test, t-test). Results: In patients ≥18 months of age, only orbital metastasis was associated with decreased 5YS (P = 0.0323) and OS (P = 0.0288). In patients <18 months of age, neither orbital, calvarial, or nonorbital bone metastasis was associated with OS or 5YS. Periorbital ecchymosis was associated with higher number of involved orbital bones (P = 0.0135), but not location or survival. Conclusions: In patients ≥ 18 months of age with stage M neuroblastoma, orbital metastatic disease is associated with decreased 5YS and OS. In future clinical trials, orbital disease may be useful as an imaging-based risk factor for substratification of stage M neuroblastoma.

AB - Background: Approximately 30% of patients with metastatic (stage M) neuroblastoma present with periorbital ecchymosis from orbital osseous disease. Though locoregional disease is staged by imaging, the prognostic significance of metastatic site in stage M disease is unknown. We hypothesize that, compared to nonorbital metastasis, orbital metastasis is associated with decreased survival in patients with stage M neuroblastoma, and that periorbital ecchymosis reflects location and extent of orbital disease. Procedure: Medical records and imaging from 222 patients with stage M neuroblastoma seen at St. Jude Children's Research Hospital between January 1995 and May 2009 were reviewed. Thirty-seven patients were <18 months of age at diagnosis and 185 were ≥18 months of age. Overall survival (OS) and 5-year survival (5YS) were compared for patients with and without orbital, calvarial and nonorbital osseous metastasis, and with and without periorbital ecchymosis (log-rank test). Associations of periorbital ecchymosis with orbital metastasis location/extent were explored (Fisher's exact test, t-test). Results: In patients ≥18 months of age, only orbital metastasis was associated with decreased 5YS (P = 0.0323) and OS (P = 0.0288). In patients <18 months of age, neither orbital, calvarial, or nonorbital bone metastasis was associated with OS or 5YS. Periorbital ecchymosis was associated with higher number of involved orbital bones (P = 0.0135), but not location or survival. Conclusions: In patients ≥ 18 months of age with stage M neuroblastoma, orbital metastatic disease is associated with decreased 5YS and OS. In future clinical trials, orbital disease may be useful as an imaging-based risk factor for substratification of stage M neuroblastoma.

UR - http://www.scopus.com/inward/record.url?scp=84959510209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959510209&partnerID=8YFLogxK

U2 - 10.1002/pbc.25847

DO - 10.1002/pbc.25847

M3 - Article

C2 - 26599346

AN - SCOPUS:84959510209

VL - 63

SP - 627

EP - 633

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 4

ER -